Lypho-Med Remedies Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 21-12-2024
- Paid Up Capital ₹ 2.70 M
as on 21-12-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.51 Cr
as on 21-12-2024
- Revenue 0.89%
(FY 2020)
- Profit 165.26%
(FY 2020)
- Ebitda 208.67%
(FY 2020)
- Net Worth 4.86%
(FY 2020)
- Total Assets 0.94%
(FY 2020)
About Lypho-Med Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.70 M.
The company has closed loans amounting to ₹2.51 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kaushik Patel, Vijaykumar Lavri, and Haresh Radadiya serve as directors at the Company.
- CIN/LLPIN
U24231GJ1999PTC036282
- Company No.
036282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lypho-Med Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushik Patel  | Director | 13-Jul-1999 | Current |
| Vijaykumar Lavri | Director | 13-Jul-1999 | Current |
| Haresh Radadiya | Director | 13-Jul-1999 | Current |
Financial Performance of Lypho-Med Remedies.
Lypho-Med Remedies Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.89% increase. The company also saw a substantial improvement in profitability, with a 165.26% increase in profit. The company's net worth moved up by a moderate rise of 4.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lypho-Med Remedies?
In 2019, Lypho-Med Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 23 Jan 2009 | ₹0.50 M | Satisfied |
Bank Of India Creation Date: 23 Jan 2009 | ₹5.00 M | Satisfied |
Bank Of India Creation Date: 19 Sep 2006 | ₹4.50 M | Satisfied |
How Many Employees Work at Lypho-Med Remedies?
Unlock and access historical data on people associated with Lypho-Med Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lypho-Med Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lypho-Med Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
